Thomas J. Riga - 31 Dec 2021 Form 5 Insider Report for SPECTRUM PHARMACEUTICALS INC

Role: CEO & President, Director
Signature: /s/ Kurt A. Gustafson, attorney-in-fact for Thomas J. Riga
Issuer symbol: N/A
Transactions as of: 31 Dec 2021
Net transactions value: $0
Form type: 5
Filing time: 14 Feb 2022, 15:05:53 UTC
Previous filing: 14 May 2021
Next filing: 24 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SPPI	Common Stock, $0.001 par value	Award	$0	+239,500	+59%	$0.000000	646,379	30 Dec 2021	Direct	F1
holding	SPPI	Common Stock, $0.001 par value						14,139	31 Dec 2021	By 401(k) plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SPPI	Stock Option (Right to Buy)	Award	$0	+1,078,500		$0.000000	1,078,500	30 Dec 2021	Common Stock	1,078,500	$1.29	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One third of the aggregate amount of restricted shares shall vest on each of December 30, 2022, 2023 and 2024, respectively.
F2	One third of the aggregate amount of option shares shall vest on each of December 30, 2022, 2023 and 2024, respectively.